Susan Altschuller
Director of Finance/CFO at CEREVEL THERAPEUTICS HOLDINGS, INC.
Net worth: 714 913 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Caroline Loew | M | 54 | 1 years | |
| James Collins | M | 62 |
Vestaron Corp.
 Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | 1 years |
| Gabrielle Greene-Sulzberger | F | 63 |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 5 years |
| Suneet Varma | M | 55 |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 2 years |
| Deborah Baron | F | 55 |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 3 years |
| Adam Koppel | M | 54 |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 6 years |
| Christopher Gordon | M | 51 |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 6 years |
| Ronald Renaud | M | 55 | 1 years | |
| N. Coles | M | 63 | 6 years | |
| Norbert Riedel | M | 66 |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 6 years |
| Marijn Dekkers | M | 65 |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 6 years |
| Deval Patrick | M | 67 |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 4 years |
| Ruth McKernan | M | 66 |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 4 years |
| Juan Estupinan | M | - |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | 2 years |
| Douglas Giordano | M | 61 |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | 6 years |
| Benjamin Hickey | M | 50 | 1 years | |
| Kathleen Tregoning | F | 53 | 4 years | |
| Scott Akamine | M | 40 | 3 years | |
| Gianluca Pirozzi | M | 47 | 5 years | |
| Daniel Char | M | 63 | 2 years | |
| Maiken Keson-Brookes | F | 52 | 1 years | |
| Robert M. Kennedy | M | - |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | 15 years |
| Mark Bodenrader | M | 51 | 5 years | |
| Adam Daniel Cutler | M | 50 | 1 years | |
| Francis Cuss | M | 69 | 1 years | |
| Vicki Goodman | M | 55 | 1 years | |
| Kartik Dharmadhikari | M | - |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | 4 years |
| Anna Robinson | F | - | - | |
| Tamar Thompson | F | 50 | 5 years | |
| Raymond Sanchez | M | 63 | 5 years | |
| Kenneth DiPietro | M | 65 | 5 years | |
| Adam Wieschhaus | M | 41 |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | 3 years |
| John Renger | M | 55 | 5 years | |
| Jason Noel | M | - |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | 5 years |
| Paul Burgess | M | 50 | 1 years | |
| Mary Margaret Huizinga | M | 47 | 2 years | |
| Matthew Calistri | M | - | - | |
| Philip Austin | M | - |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | 10 years |
| Ron L. Meeusen | M | 72 |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | - |
| Scott Jackson | M | 60 | 1 years | |
| Ariel Barack | M | - |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David G. Foster | M | - | 3 years | |
| Helen Thackray | M | 55 | 3 years | |
| Tina Beamon | F | - | 3 years | |
| Thomas Ryll | M | 64 | 6 years | |
| Judith Reinsdorf | F | 60 | 3 years | |
| John C. King | M | 49 | 9 years | |
| Michael V. Greco | M | 53 | 11 years | |
| Tracey McCain | F | 56 | 3 years | |
| Deborah Dunsire | M | 61 | 3 years | |
| Ellen Chiniara | F | 65 | 3 years | |
| Alvin S. Parven | M | 83 | 19 years | |
| M. Burns | F | 66 | 4 years | |
| Elena Ridloff | F | 44 | 4 years | |
| Uzair Qadeer | M | - | 2 years | |
| Kristen Stants | F | 51 | 2 years | |
| Adam Hansard | M | 48 | 1 years | |
| Mohammed Qatanani | M | 50 | 3 years | |
| Matthew DeLawder | M | - | 5 years | |
| Julia Wang | F | 53 | 2 years | |
| Lisa Trivison Beck | F | 62 | 3 years | |
| Christopher Benecchi | M | - | 2 years | |
| Kristen Harrington-Smith | F | 51 | 1 years | |
| Thierry Chauche | M | 48 | - | |
| Christopher Wick | M | - | 4 years | |
| Kenny Chan | M | - | - | |
| Brian Krex | M | 57 | 4 years | |
| Jens Renstrup | M | 59 | 3 years | |
| Paul Clancy | M | 62 | 2 years | |
| Jacques Suzanne | F | 53 | 2 years | |
| Matthew Batters | M | 48 | 4 years | |
| Jose Menoyo | M | - | 3 years | |
| Julie O'Neill | F | 58 | 3 years | |
| Jing Marantz | M | 59 | 2 years | |
| Christopher J. Stevo | M | - | 1 years | |
| Steven Ryder | M | 73 | 5 years | |
| John Moriarty | M | 56 | 6 years | |
| Tanisha Cariño | M | 49 | 2 years | |
| Heidi Wagner | F | 59 | 9 years | |
| Camille Bedrosian | M | 71 | 10 years | |
| Laura Gault | F | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 74 | 91.36% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Susan Altschuller
- Personal Network
